1. From the Division of Endocrinology, Diabetes, and Hypertension (F.B., Y.T., E.C., W.A.H.), David Geffen School of Medicine, University of California, Los Angeles, Calif; the Department of Medicine/Cardiology (F.B.), German Heart Institute, Berlin, Germany; and the Department of Medical and Scientific Affairs (R.E.L.), Takeda Pharmaceuticals North America, Inc, Lincolnshire, Ill.